Katsuyoshi Hashine

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet · 2017 · 175 citations · Full text

Platinum-based Therapy, Urology, Metastatic Urothelial Carcinoma +8

Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan

Yoichi Arai, Shin Egawa, Ken‐ichi Tobisu et al. · British Journal of Urology · 2000 · 86 citations

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet Oncology · 2019 · 83 citations · Full text

Platinum-based Therapy, Urology, Genitourinary Cancer +8

Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction

Siew‐Kee Low, Koya Fukunaga, Atsushi Takahashi et al. · PLoS ONE · 2016 · 46 citations · Full text

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

Hiroyoshi Suzuki, Toshitaka Shin, Satoshi Fukasawa et al. · Japanese Journal of Clinical Oncology · 2020 · 44 citations · Full text